Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 159
Filter
1.
J Environ Manage ; 351: 119845, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38109825

ABSTRACT

Pyrogallol promotes free radicals leading to oxidative stress and toxicity. There are however a lack of studies on oxidative stress and the antioxidant system of fish following exposure to pyrogallol. This study measured oxidative stress markers, antioxidant responses, and histological changes in catfish exposed to pyrogallol. Fish were divided into one of four experimental groups: control only, or 1, 5 or 10 mg/L pyrogallol. After 15 days, glutathione-S-transferase in the serum was decreased in fish exposed to either 5 or 10 mg/L pyrogallol relative to controls while superoxide dismutase and total antioxidant capacity were decreased significantly in fish exposed to 1, 5, or 10 mg/L pyrogallol. Conversely, catalase was increased in serum of fish exposed to 1, 5, or 10 mg/L pyrogallol compared to controls. The liver of fish treated with 1, 5, or 10 mg/L pyrogallol had significantly higher levels of oxidative stress markers (malondialdehyde, lipid peroxidation, hydroperoxide content, oxidised protein content, and DNA fragmentation %) that varied with concentration. Catfish exposed to either 1, 5, or 10 mg/L pyrogallol presented with notable histological alterations in the intestine, kidney, and muscles with prominent fibrosis, as intense deposition of collagen fibre was observed by Masson's trichrome staining. Overall, endpoints related to oxidative stress and antioxidant defence enzymes in fish may be early biomarkers of pyrogallol exposure and contamination in aquatic ecosystems. Additional studies should characterize oxidative stress indicators for their utility as biomarkers of effect.


Subject(s)
Catfishes , Water Pollutants, Chemical , Animals , Antioxidants/metabolism , Pyrogallol/toxicity , Pyrogallol/metabolism , Ecosystem , Oxidative Stress , Catfishes/metabolism , Biomarkers/metabolism , Lipid Peroxidation , Water Pollutants, Chemical/toxicity , Water Pollutants, Chemical/metabolism
2.
Int J Biol Macromol ; 226: 853-869, 2023 Jan 31.
Article in English | MEDLINE | ID: mdl-36526063

ABSTRACT

Acinetobacter baumannii, a virulent uropathogen with widespread antibiotic resistance, has arisen as a critical scientific challenge, necessitating the development of innovative therapeutic agents. This is the first study reveal the proteomic changes in A. baumannii upon pyrogallol treatment for understanding the mechanisms using nano-LC-MS/MS-based quantitative proteomics and qPCR analysis. The obtained results found that pyrogallol treatment dramatically downregulated the expression level of several key proteins such as GroEL, DnaK, ClpB, SodB, KatE, Bap, CsuA/B, PgaA, PgaC, BfmR, OmpA, and SecA in A. baumannii, which are involved in chaperone-mediated oxidative stress responses, antioxidant defence system, biofilm formation, virulence enzyme production, bacterial adhesion, capsule formation, and antibiotic resistance. Accordingly, the pyrogallol dramatically enhanced the lifespan of A. baumannii-infected zebrafish by inhibiting bacterial colonization, demonstrating the anti-infective potential of pyrogallol against A. baumannii. Further, the histopathological results also demonstrated the disease protection efficacy of pyrogallol against the pathognomonic sign of A. baumannii infection. In addition, the pyrogallol treatment effectively improved the immune parameters such as serum myeloperoxidase activity, leukocyte respiratory burst activity, and serum lysozyme activity in zebrafish against A. baumannii infection. Based on the results, the present study strongly proposes pyrogallol as a promising therapeutic agent for treating A. baumannii infection.


Subject(s)
Acinetobacter baumannii , Anti-Infective Agents , Animals , Virulence , Zebrafish/metabolism , Acinetobacter baumannii/metabolism , Pyrogallol/pharmacology , Pyrogallol/metabolism , Proteomics , Tandem Mass Spectrometry , Biofilms , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/metabolism , Anti-Infective Agents/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Immunity
3.
Chem Biol Interact ; 365: 110069, 2022 Sep 25.
Article in English | MEDLINE | ID: mdl-35944648

ABSTRACT

Drug-loaded nanoparticles are currently gaining attention due to their improved drug delivery properties. Apocynin, a natural polyphenolic compound, is a component of many plants. It has many medicinal and pharmacological properties. Pyrogallol is an anti-psoriatic agent. However, its clinical usage is limited due to its cumulative and dose-dependent hepatotoxicity. The objective of this study was to synthesize silver nanoparticles coated with Apocynin (Apo-AgNPs), and investigate the antioxidant and liver protective effects of Apo-AgNPs on pyrogallol-induced toxicity in rats. The nanoparticles were characterized and it was determined that the synthesis technique results in homogeneously dispersed core-shell Ag structures with spherical forms and an average diameter of 13 nm (6.3 nm). Our results showed that Apo-AgNPs exhibited potent antioxidant and excellent membrane stability activities in vitro. In rats, Apo-AgNPs (10 and 30 mg/kg) significantly prevented pyrogallol-induced elevations of alkaline phosphatase, gamma-glutamyl transferase, creatinine, urea, aspartate aminotransferase, alkaline aminotransferase, total bilirubin, and decreased blood levels of uric acid. Moreover, Apo-AgNPs restored the decreased activities of the liver antioxidant enzymes, including superoxide dismutase and glutathione peroxidase, glutathione transferase, as well as non-enzyme antioxidant glutathione, as well as significantly decreased catalase activities which were induced by pyrogallol treatment. Histological studies indicated that pyrogallol -induced liver damage was alleviated following Apo-AgNPs treatment in rats. Apo-AgNPs significantly suppressed the up-regulation of Cyclooxygenase-2 (COX-2), Interleukin 6 (IL-6) and Nuclear factor-κB (NF-κB) protein expression. These results indicated that Apo-AgNPs protected the rats from damage via preserving the antioxidant defense systems, lowering pro-inflammatory cytokines, and expression of COX-2 and NF-κB in rats.


Subject(s)
Chemical and Drug Induced Liver Injury , Metal Nanoparticles , Acetophenones , Animals , Antioxidants/metabolism , Antioxidants/pharmacology , Chemical and Drug Induced Liver Injury/drug therapy , Chemical and Drug Induced Liver Injury/metabolism , Chemical and Drug Induced Liver Injury/prevention & control , Cyclooxygenase 2/metabolism , Lipid Peroxidation , Liver , Metal Nanoparticles/chemistry , Metal Nanoparticles/toxicity , NF-kappa B/metabolism , Oxidative Stress , Pyrogallol/metabolism , Pyrogallol/pharmacology , Rats , Silver/pharmacology
4.
J Appl Toxicol ; 42(3): 423-435, 2022 03.
Article in English | MEDLINE | ID: mdl-34448506

ABSTRACT

Lignin and lignin-based materials have received considerable attention in various fields due to their promise as sustainable feedstocks. Guaiacol (G) and syringol (S) are two primary monolignols that occur in different ratios for different plant species. As methoxyphenols, G and S have been targeted as atmospheric pollutants and their acute toxicity examined. However, there is a rare understanding of the toxicological properties on other endpoints and mixture effects of these monolignols. To fill this knowledge gap, our study investigated the impact of different S/G ratios (0.5, 1, and 2) and three lignin depolymerization samples from poplar, pine, and miscanthus species on mutagenicity and developmental toxicity. A multitiered method consisted of in silico simulation, in vitro Ames test, and in vivo chicken embryonic assay was employed. In the Ames test, syringol showed a sign of mutagenicity, whereas guaiacol did not, which agreed with the T.E.S.T. simulation. For three S and G mixture and lignin monomers, mutagenic activity was related to the proportion of syringol. In addition, both S and G showed developmental toxicity in the chicken embryonic assay and T.E.S.T. simulation, and guaiacol had a severe effect on lipid peroxidation. A similar trend and comparable developmental toxicity levels were detected for S and G mixtures and the three lignin depolymerized monomers. This study provides data and insights on the differential toxicity of varying S/G ratios for some important building blocks for bio-based materials.


Subject(s)
Guaiacol/toxicity , Lignin/chemistry , Mutagenesis , Mutagens/toxicity , Pyrogallol/analogs & derivatives , Toxicity Tests , Animals , Chick Embryo , Guaiacol/metabolism , Lignin/metabolism , Mutagenicity Tests , Mutagens/metabolism , Pyrogallol/metabolism , Pyrogallol/toxicity
5.
Protein Expr Purif ; 188: 105964, 2021 12.
Article in English | MEDLINE | ID: mdl-34454050

ABSTRACT

The gene of catechol 1, 2-dioxygenase was identified and cloned from the genome of Oceanimonas marisflavi 102-Na3. The protein was expressed in Escherichia coli BL21 (DE3) and purified to homogeneity of a dimer with molecular mass of 69.2 kDa. The enzyme was highly stable in pH 6.0-9.5 and below 45 °C and exhibited the maximum activity at pH 8.0 and 30 °C. Being the first characterized intradiol dioxygenase from marine bacteria Oceanimonas sp., the enzyme showed catalytic activity for catechol, 3-methylcatechol, 4-methylcatechol, 3-chlorocatechol, 4-chlorocatechol and pyrogallol. For catechol, Km and Vmax were 11.2 µM and 13.4 U/mg of protein, respectively. The enzyme also showed resistance to most of the metal ions, surfactants and organic solvents, being a promising biocatalyst for biodegradation of aromatic compounds in complex environments.


Subject(s)
Aeromonadaceae/enzymology , Bacterial Proteins/genetics , Catechol 1,2-Dioxygenase/genetics , Catechols/metabolism , Aeromonadaceae/chemistry , Aeromonadaceae/classification , Aeromonadaceae/genetics , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Bacterial Proteins/metabolism , Catechol 1,2-Dioxygenase/chemistry , Catechol 1,2-Dioxygenase/isolation & purification , Catechol 1,2-Dioxygenase/metabolism , Catechols/chemistry , Cloning, Molecular , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Genetic Vectors/chemistry , Genetic Vectors/metabolism , Hydrogen-Ion Concentration , Kinetics , Molecular Weight , Phylogeny , Protein Multimerization , Pyrogallol/chemistry , Pyrogallol/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Substrate Specificity
6.
ACS Appl Mater Interfaces ; 13(30): 35494-35505, 2021 Aug 04.
Article in English | MEDLINE | ID: mdl-34288640

ABSTRACT

Polymer nanocapsules, with a hollow structure, are increasingly finding widespread use as drug delivery carriers; however, quantitatively evaluating the bio-nano interactions of nanocapsules remains challenging. Herein, poly(ethylene glycol) (PEG)-based metal-phenolic network (MPN) nanocapsules of three sizes (50, 100, and 150 nm) are engineered via supramolecular template-assisted assembly and the effect of the nanocapsule size on bio-nano interactions is investigated using in vitro cell experiments, ex vivo whole blood assays, and in vivo rat models. To track the nanocapsules by mass cytometry, a preformed gold nanoparticle (14 nm) is encapsulated into each PEG-MPN nanocapsule. The results reveal that decreasing the size of the PEG-MPN nanocapsules from 150 to 50 nm leads to reduced association (up to 70%) with phagocytic blood cells in human blood and prolongs in vivo systemic exposure in rat models. The findings provide insights into MPN-based nanocapsules and represent a platform for studying bio-nano interactions.


Subject(s)
Blood/metabolism , Metal-Organic Frameworks/chemistry , Nanocapsules/chemistry , Polyethylene Glycols/chemistry , Pyrogallol/analogs & derivatives , Animals , Flow Cytometry/methods , Gold/chemistry , Gold/metabolism , Gold/pharmacokinetics , Gold/toxicity , Humans , Male , Metal Nanoparticles/chemistry , Metal Nanoparticles/toxicity , Metal-Organic Frameworks/metabolism , Metal-Organic Frameworks/pharmacokinetics , Metal-Organic Frameworks/toxicity , Mice , Nanocapsules/toxicity , Particle Size , Polyethylene Glycols/metabolism , Polyethylene Glycols/pharmacokinetics , Polyethylene Glycols/toxicity , Pyrogallol/metabolism , Pyrogallol/pharmacokinetics , Pyrogallol/toxicity , RAW 264.7 Cells , Rats, Sprague-Dawley
7.
Int J Biol Macromol ; 170: 189-195, 2021 Feb 15.
Article in English | MEDLINE | ID: mdl-33333096

ABSTRACT

The activity of Horseradish Peroxidase (HRP) Enzyme exposed to a static magnetic field (SMF) during the oxidation reaction of pyrogallol (PGL) and the epigallocatechin gallate (EPCG) flavonoid was recorded at different times. As the data showed, the enzyme activity increased by 77.17% with increasing incubation time up to 30 min. The kinetic parameters KM and Vmax for PGL sample incubated in SMF for 30 min were 5.641 × 10-3 mM, 4.424 × 10-2 mmol/min, respectively, and for EPCG sample with the same condition were 8.65 × 10-4 mM, 2.37 × 10-3 mmol/min, respectively. Exposure of HRP enzyme to SMF changed the optimum pH from 7.0 to 6.0 in 10 min, but did not create any change in the optimum temperature of the enzyme. After 120 h, the residual activity of normal enzyme was 17% higher than that of the incubated enzyme. The structural changes of the control and HRP enzyme incubated in SMF were investigated by relative viscosity, fluorescence and CD, UV-Vis spectrophotometry. The structural changes in the presence of SMF were found to cause changes in the enzyme activity. In fact, changes in the amount of hydrogen bonds between enzymes and solvents can be a reason for this behavior from a molecular point of view. Using a static magnetic field can provide a new approach to control and direct enzyme-based biological processes.


Subject(s)
Horseradish Peroxidase/chemistry , Magnetic Fields , Catechin/analogs & derivatives , Catechin/metabolism , Circular Dichroism , Horseradish Peroxidase/metabolism , Hydrogen-Ion Concentration , Kinetics , Molecular Structure , Oxidation-Reduction , Pyrogallol/metabolism , Solvents , Spectrometry, Fluorescence , Spectrophotometry, Ultraviolet , Structure-Activity Relationship , Temperature , Viscosity
8.
J Environ Sci Health B ; 55(12): 1048-1060, 2020.
Article in English | MEDLINE | ID: mdl-32877269

ABSTRACT

The oxidation activity of multicopper-oxidases overlaps with different substrates of laccases and bilirubin oxidases, thus in the present study an integrated approach of bioinformatics using homology modeling, docking, and experimental validation was used to confirm the type of multicopper-oxidase in Myrothecium verrucaria ITCC-8447. The result of peptide sequence of M. verrucaria ITCC-8447 enabled to predict the 3 D-structure of multicopper-oxidase. It was overlapped with the structure of laccase and root mean square deviation (RMSD) was 1.53 Å for 533 and, 171 residues. The low binding energy with azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) (-5.64) as compared to bilirubin (-4.39) suggested that M. verrucaria ITCC-8447 have laccase-like activity. The experimental analysis confirmed high activity with laccase specific substrates, phenol (18.3 U/L), ampyrone (172.4 U/L) and, ampyrone phenol coupling (50 U/L) as compared to bilirubin oxidase substrate bilirubin (16.6 U/L). In addition, lowest binding energy with ABTS (-5.64), syringaldazine SYZ (-4.83), guaiacol GCL (-4.42), and 2,6-dimethoxyphenol DMP (-4.41) confirmed the presence of laccase. Further, complete remediation of two hazardous model pollutants i.e., phenol and resorcinol (1.5 mM) after 12 h of incubation and low binding energy of -4.32 and, -4.85 respectively confirmed its removal by laccase. The results confirmed the presence of laccase in M. verrucaria ITCC-8447 and its effective bioremediation potential.


Subject(s)
Hypocreales/enzymology , Laccase/chemistry , Laccase/metabolism , Oxidoreductases/chemistry , Oxidoreductases/metabolism , Amino Acid Sequence , Ampyrone/metabolism , Benzothiazoles/metabolism , Bilirubin/metabolism , Computer Simulation , Fungal Proteins/chemistry , Fungal Proteins/metabolism , Guaiacol/metabolism , Hydrazones/metabolism , Hydrogen-Ion Concentration , Molecular Docking Simulation , Oxidoreductases Acting on CH-CH Group Donors/chemistry , Oxidoreductases Acting on CH-CH Group Donors/metabolism , Phenol/metabolism , Protein Conformation , Pyrogallol/analogs & derivatives , Pyrogallol/metabolism , Substrate Specificity , Sulfonic Acids/metabolism
9.
Lett Appl Microbiol ; 71(5): 466-478, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32654165

ABSTRACT

Although, the application of tannic acid (TA), gallic acid (GA), natural hydrolysable tannins (HT)-rich ingredients, and HT-rich feeds in ruminant feeding have been explored in order to modify or manipulate microbial activities of digestive tract of animals, the interaction between HT and gastrointestinal microbiota and the fate of HT metabolites (GA, ellagic acid, pyrogallol, resorcinol, phloroglucinol, catechol and urolithin) derived from gastrointestinal microbial HT metabolism in the animal as a whole and animal products are missing. Incomplete biotransformation of HT and TA to GA, pyrogallol, resorcinol, phloroglucinol and other phenolic metabolites is a prevalent phenomenon discovered by researchers who examine the fate of HT metabolites in ruminant. While the rest of fellow researchers do not even examine the fate of HT metabolites and assume the complete biotransformation and fermentation of HT metabolites to volatile fatty acids (VFA). Only three studies have successfully identified the complete biotransformation and fermentation of HT metabolites to VFA in ruminant. The HT metabolites, mostly pyrogallol, produced through incomplete biotransformation of HT have adverse effects on gastrointestinal microbiota and host animal. Lack of awareness regarding the metabolism of HT metabolites and its consequences would compromise ruminant gastrointestinal microbiota, animal welfare, our environment and the power of research papers' findings. In this perspective paper, I will bring to attention a new angle on the biotransformation and fermentation of HT metabolites in gastrointestinal tract, the role of gastrointestinal microbiota and deficiency of current approach in isolating tannin-degrading bacteria from rumen. Also, suggestions for better monitoring and understanding HT metabolisms in ruminant are presented.


Subject(s)
Fatty Acids, Volatile/biosynthesis , Hydrolyzable Tannins/metabolism , Rumen/microbiology , Ruminants/metabolism , Animals , Fermentation , Gallic Acid/metabolism , Gastrointestinal Microbiome/physiology , Gastrointestinal Tract/microbiology , Pyrogallol/metabolism , Tannins/metabolism
10.
J Microbiol Biotechnol ; 30(4): 622-632, 2020 Apr 28.
Article in English | MEDLINE | ID: mdl-31581382

ABSTRACT

Phenylalanine ammonia-lyase (PAL) catalyzes the reversible deamination of phenylalanine to cinnamic acid and ammonia. Algae have been considered as biofactories for PAL production, however, biochemical characterization of PAL and its potency for myristicin biotransformation into MMDA (3-methoxy-4, 5-methylenedioxyamphetamine) has not been studied yet. Thus, PAL from Anabaena flos-aquae and Spirulina platensis has been purified, comparatively characterized and its affinity to transform myristicin was assessed. The specific activity of purified PAL from S. platensis (73.9 µmol/mg/min) and A. flos-aquae (30.5 µmol/mg/min) was increased by about 2.9 and 2.4 folds by gel-filtration comparing to their corresponding crude enzymes. Under denaturing-PAGE, a single proteineous band with a molecular mass of 64 kDa appeared for A. flos-aquae and S. platensis PAL. The biochemical properties of the purified PAL from both algal isolates were determined comparatively. The optimum temperature of S. platensis and A. flos-aquae PAL for forward or reverse activity was reported at 30°C, while the optimum pH for PAL enzyme isolated from A. flos-aquae was 8.9 for forward and reverse activities, and S. platensis PAL had maximum activities at pH 8.9 and 8 for forward and reverse reactions, respectively. Luckily, the purified PALs have the affinity to hydroaminate the myristicin to MMDA successfully in one step. Furthermore, a successful method for synthesis of MMDA from myristicin in two steps was also established. Gas chromatography-mass spectrometry (GC-MS) analysis was conducted to track the product formation.


Subject(s)
Benzyl Compounds/metabolism , Dioxolanes/metabolism , Dolichospermum flos-aquae/enzymology , Phenylalanine Ammonia-Lyase/isolation & purification , Phenylalanine Ammonia-Lyase/metabolism , Pyrogallol/analogs & derivatives , 3,4-Methylenedioxyamphetamine/analogs & derivatives , 3,4-Methylenedioxyamphetamine/metabolism , Allylbenzene Derivatives , Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Bacterial Proteins/metabolism , Biotransformation , Hydrogen-Ion Concentration , Molecular Structure , Molecular Weight , Phenylalanine Ammonia-Lyase/chemistry , Pyrogallol/metabolism , Spirulina/enzymology , Substrate Specificity , Temperature
11.
Am J Clin Nutr ; 110(6): 1424-1433, 2019 12 01.
Article in English | MEDLINE | ID: mdl-31559413

ABSTRACT

BACKGROUND: Processed meat intake is associated with a higher risk of colorectal and stomach cancers, coronary artery disease, and type 2 diabetes and with higher mortality, but the estimation of intake of different processed meat products in this heterogeneous food group in epidemiological studies remains challenging. OBJECTIVE: This work aimed at identifying novel biomarkers for processed meat intake using metabolomics. METHODS: An untargeted, multi-tiered metabolomics approach based on LC-MS was applied to 33 meat products digested in vitro and secondly to urine and plasma samples from a randomized crossover dietary intervention in which 12 volunteers consumed successively 3 processed meat products (bacon, salami, and hot dog) and 2 other foods used as controls, over 3 consecutive days. The putative biomarkers were then measured in urine from 474 subjects from the European Prospective Investigation into Cancer and Nutrition (EPIC) cross-sectional study for which detailed 24-h dietary recalls and FFQs were available. RESULTS: Syringol and 4 derivatives of syringol were found to be characteristic of in vitro digests of smoked meat products. The same compounds present as sulfate esters in urine increased at 2 and 12 h after consumption of smoked meat products (hot dog, bacon) in the intervention study. The same syringol sulfates were also positively associated with recent or habitual consumption of smoked meat products in urine samples from participants of the EPIC cross-sectional study. These compounds showed good discriminative ability for smoked meat intake with receiver operator characteristic areas under the curve ranging from 0.78 to 0.86 and 0.74 to 0.79 for short-term and habitual intake, respectively. CONCLUSIONS: Four novel syringol sulfates were identified as potential biomarkers of smoked meat intake and may be used to improve assessment of smoked meat intake in epidemiological studies. This trial was registered at clinicaltrials.gov as NCT03354130.


Subject(s)
Biomarkers/blood , Meat Products/analysis , Pyrogallol/analogs & derivatives , Aged , Cross-Sectional Studies , Diet/adverse effects , Female , Humans , Male , Meat Products/adverse effects , Metabolomics , Middle Aged , Prospective Studies , Pyrogallol/blood , Pyrogallol/metabolism
12.
Chem Res Toxicol ; 32(10): 1965-1976, 2019 10 21.
Article in English | MEDLINE | ID: mdl-31468958

ABSTRACT

Elemicin is a constituent of natural aromatic phenylpropanoids present in many herbs and spices. However, its potential to cause toxicity remains unclear. To examine the potential toxicity and associated mechanism, elemicin was administered to mice for 3 weeks and serum metabolites were examined. Enlarged livers were observed in elemicin-treated mice, which were accompanied by lower ratios of unsaturated- and saturated-lysophosphatidylcholines in plasma, and inhibition of stearoyl-CoA desaturase 1 (Scd1) mRNA expression in liver. Administration of the unsaturated fatty acid oleic acid reduced the toxicity of 1'-hydroxylelemicin, the primary oxidative metabolite of elemicin, while treatment with the SCD1 inhibitor A939572 potentiated its toxicity. Furthermore, the in vitro use of recombinant human CYPs and chemical inhibition of CYPs in human liver microsomes revealed that CYP1A1 and CYP1A2 were the primary CYPs responsible for elemicin bioactivation. Notably, the CYP1A2 inhibitor α-naphthoflavone could attenuate the susceptibility of mice to elemicin-induced hepatomegaly. This study revealed that metabolic activation of elemicin leads to SCD1 inhibition in liver, suggesting that upregulation of SCD1 may serve as potential intervention strategy for elemicin-induced toxicity.


Subject(s)
Enzyme Inhibitors/metabolism , Enzyme Inhibitors/pharmacology , Pyrogallol/analogs & derivatives , Stearoyl-CoA Desaturase/antagonists & inhibitors , Administration, Oral , Animals , Enzyme Inhibitors/administration & dosage , Male , Metabolomics , Mice , Mice, Inbred C57BL , Molecular Docking Simulation , Pyrogallol/administration & dosage , Pyrogallol/metabolism , Pyrogallol/pharmacology , Stearoyl-CoA Desaturase/metabolism
13.
J Agric Food Chem ; 67(29): 8243-8252, 2019 Jul 24.
Article in English | MEDLINE | ID: mdl-31271289

ABSTRACT

Elemicin, an alkenylbenzene constituent of natural oils of several plant species, is widely distributed in food, dietary supplements, and medicinal plants. 1'-Hydroxylation is known to cause metabolic activation of alkenylbenzenes leading to their potential toxicity. The aim of this study was to explore the relationship between elemicin metabolism and its toxicity through comparing the metabolic maps between elemicin and 1'-hydroxyelemicin. Elemicin was transformed into a reactive metabolite of 1'-hydroxyelemicin, which was subsequently conjugated with cysteine (Cys) and N-acetylcysteine (NAC). Administration of NAC could significantly ameliorate the elemicin- and 1'-hydroxyelemicin-induced cytotoxicity of HepG2 cells, while depletion of Cys with diethyl maleate (DEM) increased cytotoxicity. Recombinant human CYP screening and CYP inhibition experiments revealed that multiple CYPs, notably CYP1A1, CYP1A2, and CYP3A4, were responsible for the metabolic activation of elemicin. This study revealed that metabolic activation plays a critical role in elemicin cytotoxicity.


Subject(s)
Pyrogallol/analogs & derivatives , Activation, Metabolic , Biotransformation , Cell Survival/drug effects , Cytochrome P-450 Enzyme System/metabolism , Hep G2 Cells , Humans , Hydroxylation , Molecular Structure , Pyrogallol/chemistry , Pyrogallol/metabolism , Pyrogallol/toxicity
14.
Proc Natl Acad Sci U S A ; 116(28): 13970-13976, 2019 07 09.
Article in English | MEDLINE | ID: mdl-31235604

ABSTRACT

Microbial conversion of aromatic compounds is an emerging and promising strategy for valorization of the plant biopolymer lignin. A critical and often rate-limiting reaction in aromatic catabolism is O-aryl-demethylation of the abundant aromatic methoxy groups in lignin to form diols, which enables subsequent oxidative aromatic ring-opening. Recently, a cytochrome P450 system, GcoAB, was discovered to demethylate guaiacol (2-methoxyphenol), which can be produced from coniferyl alcohol-derived lignin, to form catechol. However, native GcoAB has minimal ability to demethylate syringol (2,6-dimethoxyphenol), the analogous compound that can be produced from sinapyl alcohol-derived lignin. Despite the abundance of sinapyl alcohol-based lignin in plants, no pathway for syringol catabolism has been reported to date. Here we used structure-guided protein engineering to enable microbial syringol utilization with GcoAB. Specifically, a phenylalanine residue (GcoA-F169) interferes with the binding of syringol in the active site, and on mutation to smaller amino acids, efficient syringol O-demethylation is achieved. Crystallography indicates that syringol adopts a productive binding pose in the variant, which molecular dynamics simulations trace to the elimination of steric clash between the highly flexible side chain of GcoA-F169 and the additional methoxy group of syringol. Finally, we demonstrate in vivo syringol turnover in Pseudomonas putida KT2440 with the GcoA-F169A variant. Taken together, our findings highlight the significant potential and plasticity of cytochrome P450 aromatic O-demethylases in the biological conversion of lignin-derived aromatic compounds.


Subject(s)
Cytochrome P-450 Enzyme System/genetics , Lignin/genetics , Protein Engineering , Pyrogallol/analogs & derivatives , Cytochrome P-450 Enzyme System/chemistry , Lignin/biosynthesis , Lignin/metabolism , Methylation , Oxidation-Reduction , Oxidoreductases, O-Demethylating/chemistry , Oxidoreductases, O-Demethylating/genetics , Pseudomonas putida/enzymology , Pseudomonas putida/genetics , Pyrogallol/chemistry , Pyrogallol/metabolism
15.
Biomed Chromatogr ; 33(10): e4630, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31243785

ABSTRACT

A new capillary electrophoresis method was developed to study the synergistic effect of superoxide dismutase and jujuboside A or B on scavenging superoxide anion radical in serum matrix respectively, in which superoxide anion radical was generated from pyrogallol autoxidation. The electrophoresis conditions, and the factors affecting the productive rate of purpurogallin, such as pyrogallol autoxidation product and the activity of superoxide dismutase, were optimized. Under optimal conditions, the content of superoxide dismutase in Gibco newborn calf serum was 7.06 mg/L, RSD was 2.01% and the average recovery was 98.4%. The values of IC50 for jujuboside A and B in the serum matrix were 157.67 and 31.60 mg/L respectively, and they both had synergy on scavenging superoxide anion radical with superoxide dismutase, but there was no the dose-dependency on this synergy.


Subject(s)
Electrophoresis, Capillary/methods , Saponins/pharmacology , Superoxide Dismutase/pharmacology , Superoxides , Anions/analysis , Anions/metabolism , Drug Synergism , Free Radical Scavengers/pharmacology , Linear Models , Pyrogallol/analysis , Pyrogallol/chemistry , Pyrogallol/metabolism , Reproducibility of Results , Superoxides/analysis , Superoxides/metabolism
16.
J Agric Food Chem ; 67(15): 4328-4336, 2019 Apr 17.
Article in English | MEDLINE | ID: mdl-30912427

ABSTRACT

Myristicin is widely distributed in spices and medicinal plants. The aim of this study was to explore the role of metabolic activation of myristicin in its potential toxicity through a metabolomic approach. The myristicin- N-acetylcysteine adduct was identified by comparing the metabolic maps of myristicin and 1'-hydroxymyristicin. The supplement of N-acetylcysteine could protect against the cytotoxicity of myristicin and 1'-hydroxymyristicin in primary mouse hepatocytes. When the depletion of intracellular N-acetylcysteine was pretreated with diethyl maleate in hepatocytes, the cytotoxicity induced by myristicin and 1'-hydroxymyristicin was deteriorated. It suggested that the N-acetylcysteine adduct resulting from myristicin bioactivation was closely associated with myristicin toxicity. Screening of human recombinant cytochrome P450s (CYPs) and treatment with CYP inhibitors revealed that CYP1A1 was mainly involved in the formation of 1'-hydroxymyristicin. Collectively, this study provided a global view of myristicin metabolism and identified the N-acetylcysteine adduct resulting from myristicin bioactivation, which could be used for understanding the mechanism of myristicin toxicity.


Subject(s)
Benzyl Compounds/metabolism , Benzyl Compounds/toxicity , Dioxolanes/metabolism , Dioxolanes/toxicity , Hepatocytes/drug effects , Pyrogallol/analogs & derivatives , Acetylcysteine/chemistry , Acetylcysteine/metabolism , Activation, Metabolic , Allylbenzene Derivatives , Animals , Benzyl Compounds/chemistry , Cell Survival/drug effects , Cells, Cultured , Cytochrome P-450 CYP1A1/metabolism , Dioxolanes/chemistry , Hepatocytes/cytology , Humans , Male , Mice , Mice, Inbred C57BL , Pyrogallol/chemistry , Pyrogallol/metabolism , Pyrogallol/toxicity
17.
J Biomol Struct Dyn ; 37(11): 2766-2775, 2019 Jul.
Article in English | MEDLINE | ID: mdl-30052121

ABSTRACT

In the present study, the interaction of Pyrogallol (PG) with human serum albumin (HSA) was investigated by UV, fluorescence, Circular dichroism (CD), and molecular docking methods. The results of fluorescence experiments showed that the quenching of intrinsic fluorescence of HSA by PG was due to a static quenching. The calculated binding constants (K) for PG-HSA at different temperatures were in the order of 104 M -1, and the corresponding numbers of binding sites, n were approximately equal to unity. The thermodynamic parameters, ΔH and ΔS were calculated to be negative, which indicated that the interaction of PG with HSA was driven mainly by van der Waals forces and hydrogen bonds. The negative value was obtained for ΔG showed that the reaction was spontaneous. In addition, the effect of PG on the secondary structure of HSA was analyzed by performing UV-vis, synchronous fluorescence, and CD experiments. The results indicated that PG induced conformational changes in the structure of HSA. According to Förster no-radiation energy transfer theory, the binding distance of HSA to PG was calculated to be 1.93 nm. The results of molecular docking calculations clarified the binding mode and the binding sites which were in good agreement with the results of experiments. Communicated by Ramaswamy H. Sarma.


Subject(s)
Molecular Docking Simulation , Pyrogallol/metabolism , Serum Albumin, Human/metabolism , Spectrometry, Fluorescence/methods , Binding Sites , Biophysical Phenomena , Humans , Protein Binding , Protein Conformation , Pyrogallol/chemistry , Serum Albumin, Human/chemistry , Thermodynamics
18.
Int J Biol Macromol ; 121: 463-471, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30326223

ABSTRACT

Pyrogallol is naturally found in aquatic plant and has been proposed as a substrate of tyrosinase. In this study, we evaluated the dual effect of pyrogallol on tyrosinase as an inhibitor in the presence of L­DOPA simultaneously via integrating methods of enzyme kinetics and computational molecular dynamics (MD) simulations. Pyrogallol was found to be a reversible inhibitor of tyrosinase in the presence of L­DOPA and its induced mechanism was the parabolic non-competitive inhibition type (IC50 = 0.772 ±â€¯0.003 mM and Ki = 0.529 ±â€¯0.022 mM). Kinetic measurements by real-time interval assay showed that pyrogallol induced rapid inactivation process composing with slight activations at the low dose. Spectrofluorimetry studies showed that pyrogallol mainly induced regional changes in the active site of tyrosinase accompanying with hydrophobic disruption at high dose. The computational MD simulations further revealed that pyrogallol could interact with several residues near the tyrosinase active site pocket such as HIS61, HIS85, HIS259, ASN260, HIS263, VAL283, and ALA296. Our study provides insight into the mechanism by which hydroxyl group composing pyrogallol inhibit tyrosinase and pyrogallol is a potential natural anti-pigmentation agent.


Subject(s)
Molecular Dynamics Simulation , Monophenol Monooxygenase/chemistry , Monophenol Monooxygenase/metabolism , Pyrogallol/pharmacology , Catalytic Domain , Kinetics , Molecular Docking Simulation , Monophenol Monooxygenase/antagonists & inhibitors , Pyrogallol/metabolism
19.
Cardiovasc Toxicol ; 19(2): 156-167, 2019 04.
Article in English | MEDLINE | ID: mdl-30302669

ABSTRACT

Cardiovascular disease (CVD) is a public health concern, and the third cause of death worldwide. Several epidemiological studies and experimental approaches have demonstrated that consumption of polyphenol-enriched fruits and vegetables can promote cardioprotection. Thus, diet plays a key role in CVD development and/or prevention. Physiological ß-adrenergic stimulation promotes beneficial inotropic effects by increasing heart rate, contractility and relaxation speed of cardiomyocytes. Nevertheless, chronic activation of ß-adrenergic receptors can cause arrhythmias, oxidative stress and cell death. Herein the cardioprotective effect of human metabolites derived from polyphenols present in berries was assessed in cardiomyocytes, in response to chronic ß-adrenergic stimulation, to disclose some of the underlying molecular mechanisms. Ventricular cardiomyocytes derived from neonate rats were treated with three human bioavailable phenolic metabolites found in circulating human plasma, following berries' ingestion (catechol-O-sulphate, pyrogallol-O-sulphate, and 1-methylpyrogallol-O-sulphate). The experimental conditions mimic the physiological concentrations and circulating time of these metabolites in the human plasma (2 h). Cardiomyocytes were then challenged with the ß-adrenergic agonist isoproterenol (ISO) for 24 h. The presence of phenolic metabolites limited ISO-induced mitochondrial oxidative stress. Likewise, phenolic metabolites increased cell beating rate and synchronized cardiomyocyte beating population, following prolonged ß-adrenergic receptor activation. Finally, phenolic metabolites also prevented ISO-increased activation of PKA-cAMP pathway, modulating Ca2+ signalling and rescuing cells from an arrhythmogenic Ca2+ transients' phenotype. Unexpected cardioprotective properties of the recently identified human-circulating berry-derived polyphenol metabolites were identified. These metabolites modulate cardiomyocyte beating and Ca2+ transients following ß-adrenergic prolonged stimulation.


Subject(s)
Cardiotonic Agents/pharmacology , Catechols/pharmacology , Isoproterenol/pharmacology , Myocardial Contraction/drug effects , Myocytes, Cardiac/drug effects , Pyrogallol/pharmacology , Animals , Animals, Newborn , Biotransformation , Calcium Signaling/drug effects , Catechols/metabolism , Cell Line , Cyclic AMP/metabolism , Cyclic AMP-Dependent Protein Kinases/metabolism , Mitochondria, Heart/drug effects , Mitochondria, Heart/metabolism , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/pathology , Oxidative Stress/drug effects , Pyrogallol/metabolism , Rats, Wistar , Reactive Oxygen Species/metabolism , Time Factors
20.
Appl Microbiol Biotechnol ; 102(23): 10005-10015, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30242435

ABSTRACT

Pyrogallol is a valuable phenolic compound and displays various physiological and pharmaceutical functions. Chemical synthesis of pyrogallol suffered from many issues, including environmental pollution, high cost, and low yield. Here, to address the above drawbacks, an artificial pathway for de novo pyrogallol production was established and this pathway only needed two exogenous enzymes (Y385F/T294A PobA and 3,4-dihydroxybenzoic acid decarboxylase (PDC)). Y385F/T294A PobA is a mutant of PobA which is a hydroxylase from Pseudomonas aeruginosa, while PDC is a decarboxylase from Klebsiella pneumoniae subsp. pneumoniae. First, the conversion efficiency of PDC was tested and 1800 ± 100 mg/L pyrogallol was generated from 4 g/L gallic acid (GA). Subsequently, assembly of the whole pathway enabled 33 ± 6 mg/L pyrogallol production from simple carbon sources. After that, based on the assembling property of CipA (a hydrophobic protein) and to enhance the hydroxylation of 3,4-dihydroxybenzoic acid, CipA was employed to organize its fusion (Y385F/T294A PobA) into protein crystalline inclusions (PCIs). Remarkably, the formation of CipA-Y385F/T294A PobA PCIs increased the pyrogallol production to 60 ± 6 mg/L, a 1.8 ± 0.4-fold higher value as compared to the strain without enzyme self-assembly. Additionally, the titer of pyrogallol was enhanced to 80 ± 1 mg/L through yeast extract concentration optimization. This work not only realizes the biosynthesis of pyrogallol from renewable carbon sources but also demonstrates that using CipA-mediating enzyme self-assembly could reinforce the hydroxylation efficiency of Y385F/T294A PobA, resulting in the enhancement of pyrogallol production.


Subject(s)
Carboxy-Lyases/metabolism , Escherichia coli/metabolism , Mixed Function Oxygenases/metabolism , Pyrogallol/metabolism , Carbon/metabolism , Culture Media/chemistry , DNA, Bacterial/genetics , Escherichia coli/genetics , Gallic Acid/metabolism , Hydroxybenzoates/metabolism , Inclusion Bodies/metabolism , Indoles/metabolism , Industrial Microbiology , Klebsiella pneumoniae/enzymology , Propionates/metabolism , Pseudomonas aeruginosa/enzymology
SELECTION OF CITATIONS
SEARCH DETAIL
...